SCHOLARLY PUBLICATION ✓ Open Access

Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

📖 The Lancet Diabetes & Endocrinology 📅 2020-08-13 🔗 DOI: 10.1016/s2213-8587(20)30271-0

📄 Abstract

The abstract has not yet been added. Use the official source link for the complete publication record.

ℹ️ Publication Details

Journal: The Lancet Diabetes & Endocrinology
Published: 2020-08-13
DOI: 10.1016/s2213-8587(20)30271-0
OpenAlex: W3048686971
Access: ✓ Open Access

📋 Cite This Paper

Naomi Holman, Peter Knighton, Partha S. Kar, Jackie OʼKeefe, Matt Curley, Andy Weaver, Emma Barron, Chirag Bakhai, Kamlesh K. Khunti, Nicholas J. Wareham, Naveed A. Sattar, Bob Young, Jonathan Valabhji (2020). Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(20)30271-0

🔬 Related Research Papers

The Lancet Diabetes & Endocrinology

Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)

Ranjit Mohan Anjana, Ranjit Unnikrishnan et al. 2023-06-07 · Read paper → The Lancet Diabetes & Endocrinology

Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial

Edward Gregg, John M. Jakicic et al. 2016-09-07 · Read paper → The Lancet Diabetes & Endocrinology

Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial

Richard E. Pratley, Vanita R. Aroda et al. 2018-02-01 · Read paper → The Lancet Diabetes & Endocrinology

Polycystic ovary syndrome

Anju Elizabeth Joham, Robert John Norman et al. 2022-08-04 · Read paper → The Lancet Diabetes & Endocrinology

Endocrine-disrupting chemicals: implications for human health

Linda G. Kahn, Claire Philippat et al. 2020-07-21 · Read paper → The Lancet Diabetes & Endocrinology

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment

† 2014-05-16 · Read paper → The Lancet Diabetes & Endocrinology

📄 Abstract

🔬 Related Research Papers

Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)

Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial

Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial

Polycystic ovary syndrome

Endocrine-disrupting chemicals: implications for human health

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

Type 2 diabetes in adolescents and young adults

The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies

Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications

Obesity, inflammation, and the gut microbiota